Extendicare Inc. (TSE:EXE - Get Free Report) declared a monthly dividend on Monday, June 30th, TickerTech Dividends reports. Shareholders of record on Tuesday, July 15th will be given a dividend of 0.042 per share on Tuesday, July 15th. This represents a $0.50 dividend on an annualized basis and a yield of 3.56%. The ex-dividend date is Monday, June 30th.
Extendicare Price Performance
Shares of EXE traded up C$0.29 during mid-day trading on Tuesday, reaching C$14.14. 311,443 shares of the company's stock were exchanged, compared to its average volume of 182,794. The company has a quick ratio of 0.98, a current ratio of 0.62 and a debt-to-equity ratio of 283.02. The company has a market cap of C$1.18 billion, a price-to-earnings ratio of 18.03 and a beta of 1.26. The company has a 50-day simple moving average of C$14.15 and a two-hundred day simple moving average of C$12.50. Extendicare has a 52-week low of C$7.10 and a 52-week high of C$15.24.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on EXE shares. TD Securities lifted their price target on shares of Extendicare from C$13.00 to C$15.00 and gave the stock a "hold" rating in a research note on Thursday, May 22nd. BMO Capital Markets increased their target price on shares of Extendicare from C$13.50 to C$14.50 in a research note on Monday, May 12th.
View Our Latest Report on EXE
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
